APA

Dieckmann A., Kriebel M., Andriambeloson E., Ziegler D. & Elmlinger M. (20120710). Treatment with Actovegin® improves sensory nerve function and pathology in streptozotocin-diabetic rats via mechanisms involving inhibition of PARP activation. : Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Chicago

Dieckmann A, Kriebel M, Andriambeloson E, Ziegler D and Elmlinger M. 20120710. Treatment with Actovegin® improves sensory nerve function and pathology in streptozotocin-diabetic rats via mechanisms involving inhibition of PARP activation. : Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Harvard

Dieckmann A., Kriebel M., Andriambeloson E., Ziegler D. and Elmlinger M. (20120710). Treatment with Actovegin® improves sensory nerve function and pathology in streptozotocin-diabetic rats via mechanisms involving inhibition of PARP activation. : Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

MLA

Dieckmann A, Kriebel M, Andriambeloson E, Ziegler D and Elmlinger M. Treatment with Actovegin® improves sensory nerve function and pathology in streptozotocin-diabetic rats via mechanisms involving inhibition of PARP activation. : Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association. 20120710.